Finanzwire Finanzwire
Basculer en Français
10340 Companies
214766 Keywords
144642 Articles
113793 Press releases
Headlines Articles Press releases Newron Pharmaceuticals S.p.A. Remove
  1. Home
  2. Companies
  3. Newron Pharmaceuticals S.p.A.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 03/17/2023 at 07:00, 3 years 1 month ago

    Newron to present at the 31st European Congress of Psychiatry  

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 03/14/2023 at 07:00, 3 years 1 month ago

    Newron announces 2022 financial results and provides outlook for 2023

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 02/16/2023 at 07:00, 3 years 2 months ago

    Newron reports striking one-year interim efficacy results from its Phase II clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia

    Logo of Newron Pharmaceuticals S.p.A.
  • PRESS RELEASE

    published on 01/03/2023 at 07:00, 3 years 4 months ago

    Newron announces striking six-month interim results from its exploratory clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia

    Logo of Newron Pharmaceuticals S.p.A.
Previous page
1 ... 7 8
Accesswire
  • Published on 05/04/2026 at 23:55, 1 hour 40 minutes ago

    Avant Brands Announces Voting Results from Its 2026 Annual General and Special Meeting of Shareholders

  • Published on 05/04/2026 at 23:01, 2 hours 34 minutes ago

    Copper Road Announces Closing of Non-Brokered Private Placement

  • Published on 05/04/2026 at 23:00, 2 hours 35 minutes ago

    PJX Resources Adopting Semi-Annual Financial Reporting ("SAR")

  • Published on 05/04/2026 at 22:50, 2 hours 45 minutes ago

    IBC Advanced Alloys Announces Amendment of Existing Credit Facility

  • Published on 05/04/2026 at 22:15, 3 hours 20 minutes ago

    Battery X Metals Announces Engagement of Independent Trading Group for Market-Making Services to Support Strategic Capital Markets Initiatives

View all ACCESSWIRE
EQS Group
  • Published on 05/04/2026 at 21:05, 4 hours 30 minutes ago

    EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for Q1 2026 of €47.9 million and adjusted EBITDA of €7.6 million; forecast for the continuing operations unchanged

  • Published on 05/04/2026 at 20:02, 5 hours 32 minutes ago

    EQS-Adhoc: Rheinmetall AG: Preliminary operating margin in line with market expectation; revenue below market expectation despite growth due to delays into Q2 – 2026 full-year forecast reaffirmed

  • Published on 05/04/2026 at 19:30, 6 hours 5 minutes ago

    Shareholders approve all proposals – Dr Annelise Lüscher Hämmerli and Urs Simeon elected to the Board of Directors

  • Published on 05/04/2026 at 19:00, 6 hours 35 minutes ago

    Shareholders approve all Board proposals at Annual General Meeting

  • Published on 05/04/2026 at 18:00, 7 hours 35 minutes ago

    PURE Swiss Opportunity REF (PSO)  Key details of the capital increase in May 2026

View all EQS
Les Echos
  • Published on 05/04/2026 at 20:57, 4 hours 38 minutes ago

    Covivio - Information on total number of voting rights and share capital

  • Published on 05/04/2026 at 17:59, 7 hours 36 minutes ago

    Saint-Gobain has signed an agreement for the sale of its distribution business in Brazil

  • Published on 05/04/2026 at 17:45, 7 hours 50 minutes ago

    Weekly share buyback

  • Published on 05/04/2026 at 17:40, 7 hours 55 minutes ago

    260524 BENETEAU Revenue Q1 2026

  • Published on 05/04/2026 at 17:38, 7 hours 57 minutes ago

    Reporting on share buyback transactions carried out between April 29 and April 30, 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy